Related Experiment Video
Updated: May 21, 2026
09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
[Primary hepatic neuroendocrine carcinoma].
J Dvořáčková1, J Mačák, F Fakhouri
1Ostravske Univerzity a Fakultni nemocnice v Ostrave.
Ceskoslovenska Patologie
|June 22, 2012
Summary
Primary neuroendocrine carcinoma of the liver is a rare diagnosis. Autopsy findings in a 72-year-old male suggested this rare liver tumor, despite initial suspicion of metastasis.
Area of Science:
- Hepatobiliary Medicine
- Oncology
- Pathology
Background:
- Primary neuroendocrine carcinoma of the liver is an exceptionally rare malignancy.
- It is hypothesized to originate from scattered neuroendocrine cells within the bile duct.
Observation:
- A 72-year-old male presented with weight loss and diarrhea, initially suspected to be parasitic disease due to travel history.
- Tumor infiltration of the liver was identified, and fine needle aspiration cytology confirmed neuroendocrine carcinoma.
- Immunohistochemical analysis revealed expression of neuroendocrine markers (chromogranin, synaptophysin, CD56, NSE) and epithelial marker AE1-AE3.
Findings:
- Extensive metastatic disease was found in the vertebrae, pelvis, long bones, and skull via various imaging modalities.
- Despite thorough investigation, no primary tumor site was identified in the gastrointestinal tract, lungs, or pancreas.
- Autopsy revealed massive, multicentric liver infiltration and histological evidence of well-differentiated neuroendocrine carcinoma with cell type transformation, supporting a primary liver origin.
Implications:
- This case highlights the diagnostic challenges in identifying primary neuroendocrine carcinoma of the liver.
- The findings underscore the importance of comprehensive autopsy in elucidating rare tumor origins.
- Further research is needed to understand the pathogenesis and improve diagnostic strategies for this rare liver cancer.
